Skip to Content

Cancers, Volume 3, Issue 1

2011 March - 78 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (78)

  • Article
  • Open Access
22 Citations
11,875 Views
12 Pages

Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro

  • Ulrike Olszewski,
  • Richard Liedauer,
  • Christoph Ausch,
  • Theresia Thalhammer and
  • Gerhard Hamilton

22 March 2011

Cancer stem cells (CSCs) seem to constitute a subpopulation of tumor cells that escape from chemotherapy and cause recurrent disease. Low proliferation rates, protection in a stem cell niche and overexpression of drug resistance proteins are consider...

  • Review
  • Open Access
39 Citations
13,191 Views
28 Pages

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer

  • Kenneth J. O’Byrne,
  • Martin P. Barr and
  • Steven G. Gray

17 March 2011

Non-small cell lung cancer (NSCLC) is the most common cause of cancer related death in the world. Cisplatin and carboplatin are the most commonly used cytotoxic chemotherapeutic agents to treat the disease. These agents, usually combined with drugs s...

  • Case Report
  • Open Access
3 Citations
8,942 Views
13 Pages

17 March 2011

The present article describes the ongoing (partial) remission of a female patient (41 years old) from estrogen receptor (ER)-positive/progesterone receptor (PR)-negative metastatic breast cancer in response to a combination treatment directed towards...

  • Review
  • Open Access
8 Citations
9,160 Views
11 Pages

16 March 2011

Colon cancer is one of the most common malignant diseases and a major cause of mortality in the Western world. Metastasis to lymph nodes and other gastrointestinal organs, especially to the liver and lungs, is most common and occurs in up to 25% of c...

  • Review
  • Open Access
137 Citations
17,342 Views
22 Pages

Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer

  • Lauren P. Blair,
  • Jian Cao,
  • Mike Ran Zou,
  • Joyce Sayegh and
  • Qin Yan

16 March 2011

Similar to genetic alterations, epigenetic aberrations contribute significantly to tumor initiation and progression. In many cases, these changes are caused by activation or inactivation of the regulators that maintain epigenetic states. Here we revi...

  • Review
  • Open Access
12 Citations
9,835 Views
21 Pages

Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies

  • Guido Santilli,
  • Mara Binda,
  • Nadia Zaffaroni and
  • Maria Grazia Daidone

16 March 2011

There is accumulating evidence that breast cancer may arise from mutated mammary stem/progenitor cells which have been termed breast cancer-initiating cells (BCIC). BCIC identified in clinical specimens based on membrane phenotype (CD44+/CD24/low an...

  • Review
  • Open Access
19 Citations
17,272 Views
18 Pages

Cancer Stem Cells in Breast Cancer

  • Ryou-u Takahashi,
  • Fumitaka Takeshita,
  • Tomohiro Fujiwara,
  • Makiko Ono and
  • Takahiro Ochiya

15 March 2011

The cancer stem cell (CSC) theory is generally acknowledged as an important field of cancer research, not only as an academic matter but also as a crucial aspect of clinical practice. CSCs share a variety of biological properties with normal somatic...

  • Article
  • Open Access
20 Citations
13,716 Views
22 Pages

The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis

  • Marianne van Dijk,
  • Eoin Murphy,
  • Ruth Morrell,
  • Steven Knapper,
  • Michael O’Dwyer,
  • Afshin Samali and
  • Eva Szegezdi

15 March 2011

Acute myeloid leukemia (AML) is an aggressive stem cell malignancy that is difficult to treat. There are limitations to the current treatment regimes especially after disease relapse, and therefore new therapeutic agents are urgently required which c...

  • Review
  • Open Access
1,562 Citations
58,458 Views
21 Pages

15 March 2011

Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell death. Depending on cell type and concentration, cisplatin induces cytotoxicity, e.g., by interference with transcription and/or DNA replication mechani...

  • Article
  • Open Access
13 Citations
9,746 Views
11 Pages

The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status

  • Martin Kruschewski,
  • Kathrin Mueller,
  • Sybille Lipka,
  • Jan Budczies,
  • Aurelia Noske,
  • Heinz Johannes Buhr and
  • Sefer Elezkurtaj

11 March 2011

The prognostic value of p53 and p21 expression in colorectal cancer is still under debate. We hypothesize that the prognostic impact of p53 expression is dependent on p21 status. The expression of p53 and p21 was immunohistochemically investigated in...

  • Review
  • Open Access
286 Citations
27,503 Views
26 Pages

Glutathione in Cancer Cell Death

  • Angel L. Ortega,
  • Salvador Mena and
  • Jose M. Estrela

11 March 2011

Glutathione (L-γ-glutamyl-L-cysteinyl-glycine; GSH) in cancer cells is particularly relevant in the regulation of carcinogenic mechanisms; sensitivity against cytotoxic drugs, ionizing radiations, and some cytokines; DNA synthesis; and cell prolifera...

  • Review
  • Open Access
24 Citations
11,818 Views
37 Pages

10 March 2011

The ErbB/EGFR/HER family of kinases consists of four homologous receptor tyrosine kinases which are important regulatory elements in many cellular processes, including cell proliferation, differentiation, and migration. Somatic mutations in, or over-...

  • Review
  • Open Access
53 Citations
15,656 Views
21 Pages

10 March 2011

Many studies have highlighted the role cancer stem cells (CSC) play in the development and progression of various types of cancer including lung and esophageal cancer. More recently, it has been proposed that the presence of CSCs affects treatment ef...

  • Review
  • Open Access
33 Citations
14,738 Views
21 Pages

Current State of Surgical Management of Pancreatic Cancer

  • Thilo Hackert,
  • Markus W. Büchler and
  • Jens Werner

10 March 2011

Pancreatic cancer is still associated with a poor prognosis and remains—as the fourth leading cause of cancer related mortality—a therapeutic challenge. Overall long-term survival is about 1–5%, and in only 10–20% of pancreatic cancer patients is pot...

  • Review
  • Open Access
4 Citations
11,687 Views
13 Pages

8 March 2011

The heart is a sophisticated endocrine gland synthesizing the atrial natriuretic peptide prohormone which contains four peptide hormones, i.e., atrial natriuretic peptide, vessel dilator, kaliuretic peptide and long-acting natriuretic peptide, which...

  • Review
  • Open Access
23 Citations
11,307 Views
17 Pages

7 March 2011

LINE-1 (Long Interspersed Nuclear Elements) and HERVs (Human Endogenous Retroviruses) are two families of autonomously replicating retrotransposons that together account for about 28% of the human genome. Genes harbored within LINE-1 and HERV retrotr...

  • Review
  • Open Access
27 Citations
10,729 Views
24 Pages

Implication of Heat Shock Factors in Tumorigenesis: Therapeutical Potential

  • Aurelie De Thonel,
  • Valerie Mezger and
  • Carmen Garrido

7 March 2011

Heat Shock Factors (HSF) form a family of transcription factors (four in mammals) which were named according to the discovery of their activation by a heat shock. HSFs trigger the expression of genes encoding Heat Shock Proteins (HSPs) that function...

  • Review
  • Open Access
132 Citations
16,587 Views
30 Pages

4 March 2011

The field of nanotechnology is currently undergoing explosive development on many fronts. The technology is expected to generate innovations and play a critical role in cancer therapeutics. Among other nanoparticle (NP) systems, there has been tremen...

  • Review
  • Open Access
24 Citations
10,664 Views
18 Pages

Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?

  • Ilaria Chiodi,
  • Cristina Belgiovine,
  • Francesca Donà,
  • A. Ivana Scovassi and
  • Chiara Mondello

4 March 2011

Tumors are generally composed of different cell types. In recent years, it has been shown that in many types of cancers a subset of cells show peculiar characteristics, such as the ability to induce tumors when engrafted into host animals, self-renew...

  • Review
  • Open Access
14 Citations
10,979 Views
12 Pages

Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer

  • Sann Sanda Khin,
  • Riko Kitazawa,
  • Takeshi Kondo,
  • Yuka Idei,
  • Masayo Fujimoto,
  • Ryuma Haraguchi,
  • Kiyoshi Mori and
  • Sohei Kitazawa

3 March 2011

Epigenetic alterations in cancer, especially DNA methylation and histone modification, exert a significant effect on the deregulated expression of cancer-related genes and lay an epigenetic pathway to carcinogenesis and tumor progression. Global hypo...

  • Review
  • Open Access
613 Citations
43,932 Views
20 Pages

Role of p53 in Cell Death and Human Cancers

  • Toshinori Ozaki and
  • Akira Nakagawara

3 March 2011

p53 is a nuclear transcription factor with a pro-apoptotic function. Since over 50% of human cancers carry loss of function mutations in p53 gene, p53 has been considered to be one of the classical type tumor suppressors. Mutant p53 acts as the domin...

  • Review
  • Open Access
63 Citations
11,629 Views
28 Pages

Targets and Mechanisms of Photodynamic Therapy in Lung Cancer Cells: A Brief Overview

  • Angela Chiaviello,
  • Ilaria Postiglione and
  • Giuseppe Palumbo

3 March 2011

Lung cancer remains one of the most common cancer-related causes of death. This type of cancer typically develops over a period of many years, and if detected at an early enough stage can be eliminated by a variety of treatments including photodynami...

  • Review
  • Open Access
19 Citations
17,832 Views
39 Pages

Cell-Centric View of Apoptosis and Apoptotic Cell Death-Inducing Antitumoral Strategies

  • Aintzane Apraiz,
  • Maria Dolores Boyano and
  • Aintzane Asumendi

3 March 2011

Programmed cell death and especially apoptotic cell death, occurs under physiological conditions and is also desirable under pathological circumstances. However, the more we learn about cellular signaling cascades, the less plausible it becomes to fi...

  • Review
  • Open Access
1 Citations
10,106 Views
26 Pages

2 March 2011

Surgery has contributed to unveil a tumor behavior that is difficult to reconcile with the models of tumorigenesis based on gradualism. The postsurgical patterns of progression include unexpected features such as distant interactions and variable rhy...

  • Review
  • Open Access
35 Citations
16,933 Views
11 Pages

Muscarinic Receptor Signaling in Colon Cancer

  • Erik C. Von Rosenvinge and
  • Jean-Pierre Raufman

2 March 2011

According to the adenoma-carcinoma sequence, colon cancer results from accumulating somatic gene mutations; environmental growth factors accelerate and augment this process. For example, diets rich in meat and fat increase fecal bile acids and colon...

  • Review
  • Open Access
17 Citations
11,692 Views
18 Pages

Inflammation and Tumor Microenvironment in Lymph Node Metastasis

  • Xuesong Wu,
  • Tomonori Takekoshi,
  • Ashley Sullivan and
  • Sam T. Hwang

1 March 2011

In nearly all human cancers, the presence of lymph node (LN) metastasis increases clinical staging and portends worse prognosis (compared to patients without LN metastasis). Herein, principally reviewing experimental and clinical data related to mali...

  • Review
  • Open Access
79 Citations
13,473 Views
14 Pages

Protein Kinase A in Cancer

  • Antonio Caretta and
  • Carla Mucignat-Caretta

28 February 2011

In the past, many chromosomal and genetic alterations have been examined as possible causes of cancer. However, some tumors do not display a clear molecular and/or genetic signature. Therefore, other cellular processes may be involved in carcinogenes...

  • Review
  • Open Access
7 Citations
9,322 Views
14 Pages

25 February 2011

Prostate cancer is one of the most common tumor diseases worldwide. Often being non-aggressive, prostate tumors in these cases do not need immediate treatment. However, about 20% of diagnosed prostate cancers tend to metastasize and require treatment...

  • Review
  • Open Access
20 Citations
14,008 Views
16 Pages

25 February 2011

Pancreatic cancer (PC) is among the deadliest cancers, with a median survival of six months. It is generally believed that infiltrating PC arises through the progression of early grade pancreatic intraepithelial lesions (PanINs). In one model of the...

  • Review
  • Open Access
30 Citations
11,716 Views
31 Pages

Growth Factor Mediated Signaling in Pancreatic Pathogenesis

  • Debashis Nandy and
  • Debabrata Mukhopadhyay

24 February 2011

Functionally, the pancreas consists of two types of tissues: exocrine and endocrine. Exocrine pancreatic disorders mainly involve acute and chronic pancreatitis. Acute pancreatitis typically is benign, while chronic pancreatitis is considered a risk...

  • Review
  • Open Access
7 Citations
14,280 Views
11 Pages

Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer

  • Barbara Bournet,
  • Adeline Pointreau,
  • Yannick Delpu,
  • Janick Selves,
  • Jerome Torrisani,
  • Louis Buscail and
  • Pierre Cordelier

24 February 2011

Endoscopic ultrasound-guided fine needle aspiration-biopsy is a safe and effective technique in diagnosing and staging of pancreatic ductal adenocarcinoma. However its predictive negative value does not exceed 50% to 60%. Unfortunately, the majority...

  • Article
  • Open Access
6 Citations
10,132 Views
16 Pages

23 February 2011

In spite of lacking evidence for effects on cancer progression itself, an increasing number of cancer patients use various types of complementary and alternative medicine (CAM). There is disagreement between CAM practitioners, researchers and clinica...

  • Article
  • Open Access
15 Citations
9,816 Views
13 Pages

Mastic Oil Inhibits the Metastatic Phenotype of Mouse Lung Adenocarcinoma Cells

  • Heleni Loutrari,
  • Sophia Magkouta,
  • Andreas Papapetropoulos and
  • Charis Roussos

23 February 2011

Mastic oil from Pistacia lentiscus variation chia, a natural combination of bioactive terpenes, has been shown to exert anti-tumor growth effects against a broad spectrum of cancers including mouse Lewis lung adenocarcinomas (LLC). However, no studie...

  • Article
  • Open Access
66 Citations
12,823 Views
39 Pages

23 February 2011

This review is focused on a novel cellular probe, the plasmonic nanobubble (PNB), which has the dynamically tunable and multiple functions of imaging, diagnosis, delivery, therapy and, ultimately, theranostics. The concept of theranostics was recentl...

  • Review
  • Open Access
21 Citations
13,887 Views
26 Pages

22 February 2011

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous cancer that arises in the upper aerodigestive tract. Despite advances in knowledge and treatment of this disease, the five-year survival rate after diagnosis of advanced (stage 3 and 4)...

  • Review
  • Open Access
294 Citations
26,348 Views
14 Pages

21 February 2011

Cancer stem cells (CSCs) are cells within a tumor that possess the capacity to self-renew and maintain tumor-initiating capacity through differentiation into the heterogeneous lineages of cancer cells that comprise the whole tumor. These tumor-initia...

  • Review
  • Open Access
12 Citations
9,653 Views
17 Pages

Metastatic Tumor Dormancy in Cutaneous Melanoma: Does Surgery Induce Escape?

  • William W. Tseng,
  • Niloofar Fadaki and
  • Stanley P. Leong

21 February 2011

According to the concept of tumor dormancy, tumor cells may exist as single cells or microscopic clusters of cells that are clinically undetectable, but remain viable and have the potential for malignant outgrowth. At metastatic sites, escape from tu...

  • Review
  • Open Access
16 Citations
9,782 Views
16 Pages

Involvement of COUP-TFs in Cancer Progression

  • Antoine Boudot,
  • François Le Dily and
  • Farzad Pakdel

18 February 2011

The orphan receptors COUP-TFI and COUP-TFII are members of the nuclear receptor superfamily that play distinct and critical roles in vertebrate organogenesis, as demonstrated by loss-of-function COUP-TFI and/or COUP-TFII mutant mice. Although COUP-TF...

  • Review
  • Open Access
7 Citations
9,076 Views
25 Pages

Treatment of Pancreatic Cancer: What Can We Really Predict Today?

  • Jean-Baptiste Bachet,
  • Raphael Marechal and
  • Jean-Luc Van Laethem

17 February 2011

Managing pancreatic cancer remains a big challenge due to its worse course and prognosis. However, therapeutic options and multimodal strategies are increasing nowadays, including new agents, new regimens and chemoradiation. Recently, the FOLFIRINOX...

  • Review
  • Open Access
7 Citations
9,726 Views
10 Pages

Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer

  • Volker Assfalg,
  • Norbert Hüser,
  • Christoph Michalski,
  • Sonja Gillen,
  • Jorg Kleeff and
  • Helmut Friess

14 February 2011

Palliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not...

  • Article
  • Open Access
16 Citations
11,035 Views
13 Pages

14 February 2011

Background: Bisphosphonates interfere with the mevalonate pathway and inhibit the prenylation of small GTP-binding proteins such as ras and rap. We hypothesized that zoledronic acid would synergistically inhibit T24 bladder cancer cell growth in comb...

  • Review
  • Open Access
16 Citations
10,630 Views
16 Pages

11 February 2011

Despite all improvements in both surgical and other conservative therapies, pancreatic cancer is steadily associated with a poor overall prognosis and remains a major cause of cancer mortality. Radical surgical resection has been established as the b...

  • Review
  • Open Access
13 Citations
14,530 Views
18 Pages

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer

  • Lyse A. Norian,
  • Britnie R. James and
  • Thomas S. Griffith

10 February 2011

Numerous biologic approaches are being investigated as anti-cancer therapies in an attempt to induce tumor regression while circumventing the toxic side effects associated with standard chemo- or radiotherapies. Among these, tumor necrosis factor–rel...

  • Review
  • Open Access
27 Citations
17,428 Views
15 Pages

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells

  • Philip G.R. Schmalz,
  • Michael J. Shen and
  • John K. Park

10 February 2011

Malignant gliomas are highly lethal because of their resistance to conventional treatments. Recent evidence suggests that a minor subpopulation of cells with stem cell properties reside within these tumors. These tumor stem cells are more resistant t...

  • Review
  • Open Access
36 Citations
10,593 Views
21 Pages

Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human Disease

  • Mami Takahashi,
  • Mika Hori,
  • Michihiro Mutoh,
  • Keiji Wakabayashi and
  • Hitoshi Nakagama

9 February 2011

Pancreatic cancer is difficult to cure, so its prevention is very important. For this purpose, animal model studies are necessary to develop effective methods. Injection of N-nitrosobis(2-oxopropyl)amine (BOP) into Syrian golden hamsters is known to...

  • Review
  • Open Access
7 Citations
10,295 Views
14 Pages

4 February 2011

Although cancers have been thought to be predominantly driven by acquired genetic changes, it is becoming clear that microenvironment-mediated epigenetic alterations play important roles. Aberrant promoter hypermethylation is a prevalent phenomenon i...

  • Review
  • Open Access
112 Citations
25,882 Views
21 Pages

Nerve Growth Factor in Cancer Cell Death and Survival

  • Niamh H. Molloy,
  • Danielle E. Read and
  • Adrienne M. Gorman

1 February 2011

One of the major challenges for cancer therapeutics is the resistance of many tumor cells to induction of cell death due to pro-survival signaling in the cancer cells. Here we review the growing literature which shows that neurotrophins contribute to...

  • Review
  • Open Access
29 Citations
16,208 Views
37 Pages

Protein Kinase C: An Attractive Target for Cancer Therapy

  • Barbara Marengo,
  • Chiara De Ciucis,
  • Roberta Ricciarelli,
  • Maria A. Pronzato,
  • Umberto M. Marinari and
  • Cinzia Domenicotti

1 February 2011

Apoptosis plays an important role during all stages of carcinogenesis and the development of chemoresistance in tumor cells may be due to their selective defects in the intracellular signaling proteins, central to apoptotic pathways. Consequently, ma...

  • Review
  • Open Access
13 Citations
10,291 Views
16 Pages

Diagnostic Management of Pancreatic Cancer

  • Emanuele Dabizzi,
  • Mauricio Saab Assef and
  • Massimo Raimondo

31 January 2011

Pancreatic cancer is one of the most deadly solid tumors, with an overall 5-year survival rate of less than 5%. Due to a non-specific clinical presentation, it is often diagnosed at an advanced stage and is rarely amenable for curative treatment. The...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694